Latest News

August 29, 2012
Through the Immunological Immune Project, leading university immunologists and bioinformatics experts are probing genes to better understand how immune responses are coordinated. They aim to identify new ways to manipulate the immune system to better fight disease.
June 20, 2012
Liver cancer is expected to become more common in the United States in coming years. “It’s deadly and it’s preventable,” says UCSF physician and researcher Tung Nguyen, MD.
June 20, 2012
Viral hepatitis chronically infects between 3.5 and 5.2 million people in the U.S. and more than 30,000 in San Francisco, alone — but only about one in three people who are infected know it, according to a report by the U.S. Department of Health and Human Services.
June 20, 2012
At the edge of a San Francisco neighborhood that has been riddled with drug addiction for decades, UCSF epidemiologist Kimberly Page, PhD, MPS, leads a research team that provides outreach, screening and prevention programs for drug users, those who are especially vulnerable to hepatitis C infection.
May 30, 2012
After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, and for six months after infection were better able to control the virus.
May 21, 2012
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
May 17, 2012
Viral hepatitis chronically infects between 3.5 and 5.2 million people in the U.S. – more than 30,000 in San Francisco, alone – but only about one in three people who are infected know it, according to a report by the U.S. Department of Health and Human Services.
April 24, 2012
To celebrate World Malaria Day 2012, on Wednesday, April 25, the UCSF Global Health Group and local non-profit Zagaya are hosting the Bay Area World Malaria Day Symposium.
February 29, 2012
A drug once taken by people with HIV/AIDS, but long ago shelved after newer, modern antiretroviral therapies became available, has now shed light on how the human body uses its natural immunity to fight the virus — work that could help uncover new targets for drugs.
February 03, 2012
A new analysis published this week demonstrates that confronting several diseases at once is a viable way to make the most of limited donor dollars and national health care budgets, and save more lives.

Pages